Managing uninvestigated dyspepsia in primary care

BMJ

Volumn 336, Issue 7645, 2008, Pages 623-624

  Chiba, Naoki ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

BLOATING; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSPEPSIA; EDITORIAL; EPIGASTRIC PAIN; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE POLICY; HEARTBURN; HELICOBACTER PYLORI; HUMAN; NAUSEA; PRACTICE GUIDELINE; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SATIETY; TREATMENT OUTCOME; UREA BREATH TEST; GENERAL PRACTICE; NOTE; RANDOMIZED CONTROLLED TRIAL;

DYSPEPSIA; FAMILY PRACTICE; HUMANS; PROTON PUMP INHIBITORS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 41449116378     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39497.622720.80     Document Type: Editorial

References (12)

1. Delaney BC, Qume M, Moayyedi P, Logan RFA, Ford AC, Elliott C, et al. Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial). BMJ 2008 doi: 10.1136/bmj.39479.640486.AE.
2. Chiba N, Veldhuyzen van Zanten SJO, Sinclair P, Ferguson RA, Escobedo S, Grace E. Treatment of H pylori infection in primary care patients with uninvestigated dyspepsia improves symptoms: the CADET-Hp (Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive) randomised controlled trial. BMJ 2001;324:1012-6.
3. Veldhuyzen van Zanten SJ, Chiba N, Armstrong D, Barkun A, Thomson A, Smyth S, et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: The CADET-HN study. Am J Gastroenterol 2005;100:1477-88.
4. Veldhuyzen van Zanten SJ, Flook N, Chiba N, Armstrong D, Barkun A, Bradette M, et al. An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMJ 2000;162(suppl 12):S3-23.
5. Armstrong D, Veldhuyzen van Zanten SJ, Barkun AN, Chiba N, Thomson AB, Smyth S, et al. Heartburn-dominant, uninvestigated dyspepsia: a comparison of "PPI-start" and "H2-RA-start" management strategies in primary care - the CADET-HR study. Aliment Pharmacol Ther 2005;21:1189-202.
6. Thomson AB, Barkun AN, Armstrong D, Chiba N, White RJ, Daniels S, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-prompt endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003;17:1481-91.
7. National Institute for Health and Clinical Excellence. The management of dyspepsia in adult patients in primary care. London: NICE, 2004.
8. Talley NJ, Vakil NB, Moayyedi P. American gastroenterological association technical review on the evaluation of dyspepsia. Gastroenterology 2005;129:1756-80.
9. Ford AC, Qume M, Moayyedi P, Arents NL, Lassen AT, Logan RF, et al. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology 2005;128:1838-44.
10. Chiba N, Veldhuyzen van Zanten SJ, Escobedo S, Grace E, Lee J, Sinclair P, et al. Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H pylori-positive primary care patients with uninvestigated dyspepsia. Aliment Pharmacol Ther 2004;19:349-58.
11. Chiba N, Veldhuyzen van Zanten SJO, Thomson ABR, Barkun AN, Armstrong D, Sinclair P, et al. Reflux symptoms should not be excluded from the definition of uninvestigated dyspepsia: results from the CADET-Hp study. Am J Gastroenterol 2001;96(suppl 1):A20.
12. Moayyedi P, Soo S, Deeks J, Delaney B, Harris A, Innes M, et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;(4):CD002096.